Astrazeneca Pharma India Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Astrazeneca Pharma India Ltd with 125 companies shown from the same industry classification, including Marksans Pharma Ltd, Concord Biotech Ltd, Jubilant Pharmova Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharma India Ltd | 15,078 Cr. | 6,031 | 9,850/5,978 | 86.9 | 349 | 0.60 % | 29.3 % | 23.3 % | 2.00 |
| Marksans Pharma Ltd | 14,755 Cr. | 326 | 351/155 | 28.6 | 66.7 | 0.28 % | 18.8 % | 15.2 % | 1.00 |
| Concord Biotech Ltd | 14,375 Cr. | 1,374 | 1,648/987 | 50.6 | 193 | 0.55 % | 17.4 % | 12.6 % | 1.00 |
| Jubilant Pharmova Ltd | 15,919 Cr. | 999 | 1,185/784 | 41.0 | 445 | 0.50 % | 8.99 % | 6.53 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,025 Cr. | 815 | 998/635 | 21.5 | 289 | 1.47 % | 12.6 % | 13.4 % | 2.00 |
| Natco Pharma Ltd | 16,111 Cr. | 821 | 1,217/786 | 14.1 | 470 | 0.61 % | 17.4 % | 17.1 % | 2.00 |
| ERIS Lifesciences Ltd | 16,507 Cr. | 1,190 | 1,740/1,163 | 25.2 | 282 | 0.61 % | 14.1 % | 18.7 % | 1.00 |
| Cohance Lifesciences Ltd | 17,267 Cr. | 451 | 918/267 | 160 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,654 Cr. | 3,859 | 5,578/3,792 | 23.0 | 919 | 1.94 % | 24.1 % | 18.0 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,255 Cr. | 542 | 693/325 | 43.6 | 78.4 | 0.22 % | 26.1 % | 19.4 % | 2.00 |
| Caplin Point Laboratories Ltd | 20,006 Cr. | 2,632 | 2,991/1,500 | 30.1 | 443 | 0.30 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 20,812 Cr. | 1,064 | 1,096/260 | 73.2 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Procter & Gamble Health Ltd | 8,897 Cr. | 5,360 | 6,975/4,700 | 26.7 | 316 | 2.89 % | 83.9 % | 61.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 8,782 Cr. | 968 | 1,002/584 | 40.8 | 234 | 0.36 % | 10.7 % | 8.59 % | 5.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Suven Life Sciences Ltd | 8,711 Cr. | 308 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Granules India Ltd | 22,416 Cr. | 822 | 924/520 | 34.5 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Morepen Laboratories Ltd | 7,327 Cr. | 134 | 135/33.0 | 62.4 | 22.8 | 0.15 % | 8.05 % | 5.33 % | 2.00 |
| Entero Healthcare Solutions Ltd | 7,315 Cr. | 1,681 | 1,920/944 | 56.7 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,269 Cr. | 684 | 745/118 | 52.8 | 113 | 0.22 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 6,995 Cr. | 3,037 | 4,898/3,000 | 20.4 | 359 | 2.47 % | 57.5 % | 43.0 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,146 Cr. | 209 | 219/67.1 | 34.8 | 61.3 | 0.48 % | 11.3 % | 8.42 % | 2.00 |
| Orchid Pharma Ltd | 5,929 Cr. | 990 | 1,144/471 | 328 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,469 Cr. | 336 | 476/313 | 17.8 | 153 | 1.49 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 4,969 Cr. | 382 | 479/225 | 102 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 4,847 Cr. | 2,931 | 3,130/1,731 | 41.6 | 366 | 0.82 % | 25.7 % | 19.3 % | 8.00 |
| SMS Pharmaceuticals Ltd | 4,414 Cr. | 471 | 494/253 | 48.8 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Zota Health Care Ltd | 4,391 Cr. | 1,268 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| Gufic BioSciences Ltd | 4,196 Cr. | 418 | 468/268 | 57.1 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Acutaas Chemicals Ltd | 26,170 Cr. | 3,196 | 3,740/1,373 | 67.8 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Aarti Drugs Limited | 3,842 Cr. | 421 | 534/319 | 22.2 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,767 Cr. | 535 | 687/278 | 30.8 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 3,698 Cr. | 3,564 | 3,949/829 | 45.3 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,469 Cr. | 715 | 774/422 | 812 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,436 Cr. | 395 | 425/87.0 | 52.8 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,071 Cr. | 274 | 420/252 | 19.5 | 146 | 1.95 % | 14.0 % | 10.2 % | 2.00 |
| Hikal Ltd | 2,690 Cr. | 218 | 261/146 | 63.4 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Neuland Laboratories Ltd | 27,591 Cr. | 21,505 | 24,235/11,500 | 55.4 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Venus Remedies Ltd | 2,402 Cr. | 1,797 | 2,044/432 | 20.7 | 497 | 0.56 % | 20.7 % | 15.6 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,357 Cr. | 150 | 307/128 | 130 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Indoco Remedies Ltd | 2,324 Cr. | 252 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Beta Drugs Ltd | 2,298 Cr. | 2,073 | 2,808/990 | 50.4 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,252 Cr. | 24.0 | 27.5/10.2 | 26.5 | 4.39 | 0.42 % | 24.8 % | 17.6 % | 1.00 |
| Fredun Pharmaceuticals Ltd | 2,241 Cr. | 1,355 | 1,600/427 | 50.4 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Panacea Biotec Ltd | 2,199 Cr. | 359 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Hester Biosciences Ltd | 1,809 Cr. | 2,127 | 2,684/1,239 | 34.1 | 423 | 0.52 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,628 Cr. | 553 | 580/249 | 29.8 | 138 | 0.68 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,528 Cr. | 232 | 265/155 | 32.5 | 41.2 | 1.73 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,484 Cr. | 513 | 760/476 | 23.8 | 128 | 0.95 % | 24.8 % | 18.4 % | 1.00 |
| TTK Healthcare Ltd | 1,431 Cr. | 1,013 | 1,250/735 | 18.7 | 789 | 0.99 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,363 Cr. | 282 | 296/107 | 54.5 | 110 | 1.06 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,166 Cr. | 582 | 770/440 | 12.1 | 378 | 0.31 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,042 Cr. | 113 | 147/65.0 | 43.3 | 0.44 % | 2.74 % | 0.41 % | 1.00 | |
| Bafna Pharmaceuticals Ltd | 896 Cr. | 379 | 385/94.8 | 115 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Anuh Pharma Ltd | 860 Cr. | 85.8 | 99.5/66.7 | 19.5 | 35.1 | 1.75 % | 14.9 % | 10.7 % | 5.00 |
| Kilitch Drugs (India) Ltd | 764 Cr. | 219 | 234/117 | 25.4 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Wanbury Ltd | 692 Cr. | 198 | 360/162 | 16.1 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Albert David Ltd | 489 Cr. | 857 | 932/580 | 21.7 | 686 | 0.58 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 331 Cr. | 104 | 108/50.3 | 79.4 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Lyka Labs Ltd | 295 Cr. | 81.6 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 278 Cr. | 482 | 610/340 | 23.7 | 134 | 1.04 % | 20.5 % | 14.8 % | 10.0 |
| Gennex Laboratories Ltd | 238 Cr. | 9.80 | 17.2/7.05 | 12.7 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Everest Organics Ltd | 219 Cr. | 220 | 536/197 | 41.7 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 199 Cr. | 10.2 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Coral Laboratories Ltd | 196 Cr. | 549 | 679/360 | 10.3 | 585 | 0.36 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 168 Cr. | 106 | 125/59.7 | 23.4 | 51.6 | 1.13 % | 9.69 % | 7.87 % | 10.0 |
| Brooks Laboratories Ltd | 161 Cr. | 54.8 | 138/36.3 | 12.2 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Par Drugs & Chemicals Ltd | 153 Cr. | 124 | 180/78.0 | 10.5 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 152 Cr. | 244 | 317/159 | 31.7 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 147 Cr. | 68.0 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Achyut Healthcare Ltd | 143 Cr. | 5.91 | 10.0/4.70 | 446 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Gujarat Inject (Kerala) Ltd | 134 Cr. | 9.18 | 14.3/1.96 | 44.8 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Lactose (India) Ltd | 133 Cr. | 105 | 136/76.0 | 19.1 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Godavari Drugs Ltd | 129 Cr. | 118 | 135/69.7 | 33.1 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Alpa Laboratories Ltd | 125 Cr. | 59.3 | 99.8/46.0 | 28.5 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Vaishali Pharma Ltd | 109 Cr. | 8.38 | 11.9/4.75 | 25.8 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 106 Cr. | 30.2 | 60.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Concord Drugs Ltd | 99.7 Cr. | 75.7 | 92.5/61.0 | 48.9 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 93.5 Cr. | 67.4 | 97.4/56.1 | 11.7 | 66.0 | 3.71 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 73.3 Cr. | 14.7 | 26.0/13.0 | 20.1 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 61.2 Cr. | 24.5 | 24.5/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| ANG Lifesciences India Ltd | 52.5 Cr. | 40.2 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.7 Cr. | 29.3 | 46.8/25.6 | 99.4 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Vivimed Labs Ltd | 47.3 Cr. | 5.71 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Mangalam Drugs and Organics Ltd | 46.1 Cr. | 29.2 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Bacil Pharma Ltd | 39.2 Cr. | 27.3 | 61.8/10.6 | 60.2 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.55/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Chandra Bhagat Pharma Ltd | 37.3 Cr. | 49.4 | 53.0/29.7 | 12.2 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 35.3 Cr. | 8.18 | 22.6/8.16 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Gujarat Terce Laboratories Ltd | 27.4 Cr. | 35.2 | 59.8/29.0 | 12.3 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.4 Cr. | 31.9 | 144/28.4 | 14.2 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 12.8 Cr. | 25.3 | 27.6/15.9 | 20.7 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.8 Cr. | 79.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Dipna Pharmachem Ltd | 10.9 Cr. | 4.15 | 25.0/3.90 | 4.15 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 8.80 Cr. | 15.0 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 7.38 Cr. | 24.6 | 24.7/17.7 | 8.68 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 6.06 Cr. | 6.00 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.15 Cr. | 0.78 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.78 Cr. | 1.52 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Wockhardt Ltd | 33,862 Cr. | 2,084 | 2,422/1,087 | 84.9 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 44,748 Cr. | 3,581 | 3,797/2,379 | 39.4 | 362 | 0.89 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 46,944 Cr. | 2,771 | 3,121/2,088 | 44.6 | 134 | 2.06 % | 61.4 % | 45.6 % | 10.0 |
| Gland Pharma Ltd | 47,431 Cr. | 2,874 | 3,042/1,574 | 33.6 | 656 | 0.70 % | 17.4 % | 12.8 % | 1.00 |
| Ipca Laboratories Ltd | 49,300 Cr. | 1,943 | 2,039/1,252 | 35.9 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Abbott India Ltd | 57,035 Cr. | 26,840 | 30,655/25,135 | 35.3 | 2,247 | 1.96 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 60,413 Cr. | 371 | 447/338 | 83.1 | 210 | 0.13 % | 3.61 % | 1.40 % | 5.00 |
| Alkem Laboratories Ltd | 62,413 Cr. | 5,220 | 5,934/5,051 | 27.5 | 1,156 | 1.02 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Life Sciences Ltd | 65,787 Cr. | 2,331 | 2,538/1,793 | 21.1 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 65,787 Cr. | 2,331 | 2,538/1,793 | 21.1 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 92,885 Cr. | 2,031 | 2,530/1,900 | 15.6 | 491 | 0.89 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 96,479 Cr. | 1,677 | 1,740/1,066 | 25.5 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,679 Cr. | 1,206 | 1,415/1,080 | 31.2 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,04,707 Cr. | 2,535 | 2,642/1,910 | 46.3 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Laurus Labs Ltd | 1,07,198 Cr. | 1,984 | 2,055/843 | 123 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,08,578 Cr. | 1,344 | 1,673/1,166 | 30.3 | 426 | 0.97 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,81,333 Cr. | 4,767 | 5,250/3,480 | 81.3 | 248 | 0.80 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,573.63 Cr | 1,250.16 | 55.08 | 211.24 | 0.39% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Astrazeneca Pharma India Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Astrazeneca Pharma India Ltd analysis · Explore all Pharmaceuticals stocks